C12N 2710/14134
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2710/14134 (Use of virus or viral component as vaccine) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 0
- Published applications
- 4
- Assignees
- 4
- Inventors
- 12
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
No granted patents in this class yet.
- Compositions and methods for making and using stabilized enveloped viruses by spray-drying and lyophilization2 Apr 2026US 2026/0091106 A1The Regents of the University of Colorado, a body corporate
- Oral vaccine composition23 Oct 2025US 2025/0325647 A1Kaico Ltd.
- Avian vaccines possessing a positive marker gene22 Dec 2011US 2011/0311994 A1
- Avian vaccines possessing a positive marker gene1 Oct 2009US 2009/0246226 A1Zeon Corporation
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.